Theratome Bio is a pre-clinical company developing a platform of cell-free biologics. The therapeutics cover multiple areas of unmet medical need, and offer advantages over cell-based therapies, including off-the-shelf administration, convenient freezer temperature storage and delivery, and immediate bioavailability. Current therapeutic areas under development are ischemic brain injury, concussion, acute kidney injury, and increasing the shelf life of donor organs and tissues.

Indianapolis, IN